Home › Bids › Maryland › NOI - A Non-Invasive Prognostic Biomarker - Circul

NOI - A Non-Invasive Prognostic Biomarker - Circul

Estimated Value: $250,000
Closing Soon 5 days left MarylandArchitecture & Engineeringrfp
Oct 13, 2026
Oct 23, 2026 1:00 PM
Architecture & Engineering
rfp
541380
small business
AI Summary
The National Institutes of Health (NIH) is seeking to award a firm-fixed-price purchase order on a non-competitive basis to the University of Alabama at Birmingham. The contract will fund research to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker for chlorine-induced acute lung injury. This is a streamlined solicitation for commercial items, not expected to exceed the simplified acquisition threshold.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Research Support for Development and Validation of Circulating Cell-Free DNA (cfDNA) as a Blood-Based Biomarker of Chlorine-Induced Acute Lung Injury 1 project $250,000.00 $250,000.00 Professional Services
Estimated Bid Value$250,000.00

Want the full details?

Sign up free to see the agency name and the original bid posting link. Pro adds the 1 document, contracting-officer contacts and AI response outlines.

📎 Sol_75N98027Q00007.pdf View
Sign Up Free → Already have an account? Log in

Browse More Bids

Bids in MarylandArchitecture & Engineering BidsRFP BidsClosing Soon All Bids